Peter Westervelt

Peter Westervelt

UNVERIFIED PROFILE

Are you Peter Westervelt?   Register this Author

Register author
Peter Westervelt

Peter Westervelt

Publications by authors named "Peter Westervelt"

Are you Peter Westervelt?   Register this Author

100Publications

3572Reads

15Profile Views

Shared cell of origin in a patient with Erdheim-Chester disease and acute myeloid leukemia.

Haematologica 2019 Aug 28;104(8):e373-e375. Epub 2019 Mar 28.

Division of Oncology, Department of Medicine, Washington University School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.217794DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669153PMC
August 2019

A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma.

Clin Lymphoma Myeloma Leuk 2019 May 2. Epub 2019 May 2.

Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.04.017DOI Listing
May 2019

Bone Marrow Biopsy Needle Type Affects Core Biopsy Specimen Length and Quality and Aspirate Hemodilution.

Am J Clin Pathol 2019 Jan;151(2):185-193

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcp/aqy126DOI Listing
January 2019

Immune Escape of Relapsed AML Cells after Allogeneic Transplantation.

N Engl J Med 2018 12 31;379(24):2330-2341. Epub 2018 Oct 31.

From the Division of Oncology, Department of Internal Medicine (M.J.C., A.A.P., M.P.R., C.A.M., E.C., N.M.H., L.D.W., J.S.W., S.E.H., D.C.L., M.J.W., P.W., T.J.L., J.F.D.), the McDonnell Genome Institute (A.A.P., C.A.M., M.O., C.C.F., R.S.F., L.D.W., T.J.L.), the Department of Pathology and Immunology (E.J.D., J.E.P.), and the Division of Biostatistics (J.D.B.), Washington University in St. Louis, St. Louis; the Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN (J.M.K.); the Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH (R.K.W.); and the Center for Cancer Research, Massachusetts General Hospital, Boston (T.A.G.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1808777
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1808777DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322675PMC
December 2018

HLA epitope mismatch in haploidentical transplantation is associated with decreased relapse and delayed engraftment.

Blood Adv 2018 12;2(24):3590-3601

Division of Hematologic Malignancies and Transplantation, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018025437DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306877PMC
December 2018

Propensity Score Analysis of Conditioning Intensity in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2018 10 24;24(10):2047-2055. Epub 2018 May 24.

BMT and Leukemia Program, Washington University School of Medicine, St. Louis, Missouri. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.05.024DOI Listing
October 2018

Secondary acute lymphoblastic leukemia, a retrospective analysis from Washington University and meta-analysis of published data.

Leuk Res 2018 09 31;72:86-91. Epub 2018 Jul 31.

Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.07.024DOI Listing
September 2018

Mutation Clearance after Transplantation for Myelodysplastic Syndrome.

N Engl J Med 2018 Sep;379(11):1028-1041

From the Department of Pathology and Immunology (E.J.D.), the Department of Medicine, Division of Oncology (M.A.J., C.A.M., N.E., J.S., K.E., J.R., S.E.H., K.B., L.D.W., M.J.C., I.P., J.S.W., G.L.U., D.C.L., J.F.D., P.W., T.J.L., M.J.W.), the McDonnell Genome Institute (G.S.C., C.A.M., H.A., R.S.F., C.C.F., M.O.), the Department of Medicine, Division of Hospital Medicine (R.S.), and Siteman Biostatistics Shared Resource, Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis; and Massachusetts General Hospital Cancer Center, Boston (T.A.G.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1804714
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1804714DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309244PMC
September 2018

Lack of a Prognostic Impact of the MyD88 L265P Mutation for Diffuse Large B Cell Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

Biol Blood Marrow Transplant 2017 Dec 26;23(12):2199-2204. Epub 2017 Aug 26.

Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.08.022DOI Listing
December 2017

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

J Clin Oncol 2017 Dec 17;35(36):4003-4011. Epub 2017 Oct 17.

Robert J. Soiffer, Haesook T. Kim, Vincent T. Ho, Edwin P. Alyea, and Jerome Ritz, Dana-Farber Cancer Institute; James D. Levine, Beth Israel Deaconess Medical Center and Harvard Medical School; Yi-Bin Chen, Massachusetts General Hospital, Boston; Frank Glavin, Neovii Biotech, Lexington, MA; Joseph McGuirk, University of Kansas Medical Center, Kansas City, KS; Mitchell E. Horwitz, Duke University Medical Center, Durham; Thomas C. Shea, University of North Carolina School of Medicine, Chapel Hill, NC; Laura Johnston, Stanford University, Stanford, CA; Mrinal M. Patnaik, Mayo Clinic, Rochester, MN; Witold Rybka, Penn State College of Medicine, Hershey; David L. Porter, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Andrew Artz, University of Chicago, Chicago; Patrick J. Stiff, Loyola University Medical Center, Maywood, IL; Michael W. Boyer, University of Utah, Salt Lake City, UT; Richard T. Maziarz, Oregon Health & Science University, Portland, OR; Paul J. Shaughnessy, Texas Transplant Institute, San Antonio; Madhuri Vusirikala, University of Texas Southwestern Medical Center, Dallas, TX; Usama Gergis, Weill Cornell Medical College; Ran Reshef, Columbia University Medical Center, New York, NY; Hana Safah, Tulane University, New Orleans, LA; John F. DiPersio and Peter Westervelt, Washington University School of Medicine, St Louis, MO; Jeff Szer, Royal Melbourne Hospital, Parkville, Victoria; Ian D. Lewis, Royal Adelaide Hospital, Adelaide, South Australia, Australia; Jennifer Holter, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Paul J. Martin, Fred Hutchinson Cancer Research Center, Seattle, WA; Joseph A. Pidala, H. Lee Moffitt Cancer Center, Tampa, FL; and Madan H. Jagasia, Vanderbilt University Medical Center, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.8177DOI Listing
December 2017

Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome.

Biol Blood Marrow Transplant 2017 Oct 5;23(10):1736-1743. Epub 2017 Jul 5.

BMT and Leukemia Program, Washington University School of Medicine, St. Louis, Missouri. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.06.019DOI Listing
October 2017

Allogeneic hematopoietic cell transplantation in morphologic leukemia-free aplastic state.

Am J Hematol 2017 Sep 19;92(9):E549-E552. Epub 2017 Jul 19.

Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24804DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736150PMC
September 2017

Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation.

Cancer 2017 05 6;123(10):1800-1809. Epub 2017 Mar 6.

Bone Marrow Transplant and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.30534
Publisher Site
http://dx.doi.org/10.1002/cncr.30534DOI Listing
May 2017

Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation.

Transpl Infect Dis 2017 Feb 28;19(1). Epub 2016 Dec 28.

Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tid.12629DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459579PMC
February 2017

CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.

Cell 2017 02 16;168(5):801-816.e13. Epub 2017 Feb 16.

Section of Stem Cell Biology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; The McDonnell Genome Institute, Washington University, St. Louis, MO 63110, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2017.01.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328582PMC
February 2017

Donor-Derived Smoldering Multiple Myeloma following a Hematopoietic Cell Transplantation for AML.

Case Rep Hematol 2017 20;2017:3728429. Epub 2017 Feb 20.

Washington University School of Medicine, St. Louis, MO, USA; Siteman Cancer Center, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/3728429DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337855PMC
February 2017

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

N Engl J Med 2016 11;375(21):2023-2036

the Department of Internal Medicine, Division of Oncology (J.S.W., L.D.W., G.L.U., A.G., M.H.T., I.P., R.R., T.A.F., K.E.S.-G., R.V., S.T.O., C.N.A., A.F.C., M.A.S., M.A.J., S.E.H., K.L., M.R.J., M.J.W., P.W., D.C.L., J.F.D., T.J.L.), and the Division of Biostatistics (J.D.B.), and the Department of Pathology and Immunology (E.J.D., B.T., Y.-S.L.), Washington University School of Medicine, and McDonnell Genome Institute, Washington University in St. Louis (A.A.P., C.A.M., C.C.F., M.O., R.S.F., R.K.W., L.D.W., T.J.L.) - both in St. Louis; the Departments of Internal Medicine (A.H., N.K., M.J.S., W.S.) and Pharmacy (R.W.K.), University of Chicago, Chicago; and the Department of Internal Medicine (T.A.G.), Massachusetts General Hospital, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1605949DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217532PMC
November 2016

Comparison of Outcomes after Peripheral Blood Haploidentical versus Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia: A Retrospective Single-Center Review.

Biol Blood Marrow Transplant 2016 09 17;22(9):1696-1701. Epub 2016 May 17.

Bone Marrow Transplantation and Leukemia Section, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.05.010DOI Listing
September 2016

Peritransplant Serum Albumin Decline Predicts Subsequent Severe Acute Graft-versus-Host Disease after Mucotoxic Myeloablative Conditioning.

Biol Blood Marrow Transplant 2016 06 14;22(6):1137-1141. Epub 2016 Mar 14.

Bone Marrow Transplantation and Leukemia Section, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.03.010DOI Listing
June 2016

A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia.

Cold Spring Harb Mol Case Stud 2016 Jan;2(1):a000687

McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri 63110, USA;; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a000687DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849848PMC
January 2016

Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.

Leuk Res 2015 Dec 1;39(12):1437-42. Epub 2015 Oct 1.

Division of Oncology, Washington University School of Medicine, St. Louis, MO, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2015.09.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661095PMC
December 2015

Myelodysplastic syndromes, version 2.2015.

J Natl Compr Canc Netw 2015 Mar;13(3):261-72

From Stanford Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; UC San Diego Moores Cancer Center; University of Rochester Medical Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; University of Alabama at Birmingham Comprehensive Cancer Center; Duke Cancer Institute; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Massachusetts General Hospital Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; UCSF Helen Diller Family Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Roswell Park Cancer Institute; Vanderbilt-Ingram Cancer Center; Memorial Sloan Kettering Cancer Center; Moffitt Cancer Center; University of Michigan Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center; City of Hope Comprehensive Cancer Center; University of Colorado Cancer Center; Huntsman Cancer Institute at the University of Utah; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696005PMC
March 2015

Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencing.

PLoS Genet 2014 Jul 10;10(7):e1004462. Epub 2014 Jul 10.

Department of Internal Medicine, Division of Oncology, Washington University, St. Louis, Missouri, United States of America; Siteman Cancer Center, Washington University, St. Louis, Missouri, United States of America; Department of Pathology and Immunology, Washington University, St. Louis, Missouri, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pgen.1004462DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091781PMC
July 2014

Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia.

Am J Hematol 2014 May 3;89(5):487-92. Epub 2014 Mar 3.

Department of Medicine, Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St. Louis, Missouri.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23663DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378713PMC
May 2014

Comparative evaluation of single fixed dosing and weight-based dosing of rasburicase for tumor lysis syndrome.

Pharmacotherapy 2013 Mar;33(3):295-303

Department of Pharmacy, Arthur G. James Cancer Hospital, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/phar.1198
Publisher Site
http://dx.doi.org/10.1002/phar.1198DOI Listing
March 2013

Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies.

J Hematol Oncol 2012 Dec 13;5:75. Epub 2012 Dec 13.

Arthur G, James Cancer Hospital, The Ohio State University, Department of Pharmacy, Room 368 Doan Hall, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-8722-5-75DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544586PMC
December 2012

Silybum marianum (milk thistle) in the management and prevention of hepatotoxicity in a patient undergoing reinduction therapy for acute myelogenous leukemia.

J Oncol Pharm Pract 2012 Sep 29;18(3):360-5. Epub 2012 Feb 29.

Arthur G. James Cancer Hospital, The Ohio State University Department of Pharmacy, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1078155212438252
Publisher Site
http://dx.doi.org/10.1177/1078155212438252DOI Listing
September 2012

Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation.

Biol Blood Marrow Transplant 2011 Nov 3;17(11):1646-52. Epub 2011 May 3.

Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, Department of Internal Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791110019
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2011.04.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166401PMC
November 2011

Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a phase I study.

Am J Hematol 2011 Sep 3;86(9):796-800. Epub 2011 Aug 3.

Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.22092DOI Listing
September 2011

A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia.

Blood 2011 Feb 4;117(6):1828-33. Epub 2010 Nov 4.

Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-07-297143DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318598PMC
February 2011

Clinical response of myelodysplastic syndromes patients to treatment with coenzyme Q10.

Leuk Res 2007 Jan 24;31(1):19-26. Epub 2006 Oct 24.

The Radhey Khanna MDS Center for Research, Division of Hematology, University of Massachusetts Medical Center, 364 Plantation Street, LRB 208, Worcester, MA 01605, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2006.04.009DOI Listing
January 2007

Can molecular profiling of cytogenetic subgroups draw a roadmap for individualizing therapy in myelodysplastic syndromes?

Future Oncol 2006 Jun;2(3):407-15

The Radhey Khanna Center for MDS Research, Division of Hematology, University of Massachusetts Medical Center, 364 Plantation Street, MA 01605, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14796694.2.3.407DOI Listing
June 2006

Cellular immune therapy for refractory cancers: novel therapeutic strategies.

Exp Hematol 2005 Dec;33(12):1427-35

Division of Hematology/Oncology, Massachusetts General Hospital, Boston, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2005.06.032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1986765PMC
December 2005